Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Recurrent tumor-specific transcripts as a source of neoantigens for NF1-associated malignant peripheral nerve sheath tumor immunoprevention
Largaespada, D. A. (PI), Griffin, T. J. (CoI) & Moertel, C. L. (CoI)
NIH NATIONAL CANCER INSTITUTE (NCI)
9/1/21 → 8/31/25
Project: Research project
-
PER CASE REIMBURSEMENT: BIQSFP - ACNS1831 National Clinical Trials Network (NCTN) Grant(3U10CA180886-08S1)
Moertel, C. L. (PI) & Greengard, E. G. (Prior Principal Investigator)
PUBLIC HEALTH INSTITUTE, NIH NATIONAL CANCER INSTITUTE (NCI)
3/1/21 → 2/28/25
Project: Research project
-
A Nutraceutical/Dietary Intervention for Neurofibromatosis, type 1
Largaespada, D. A. (PI) & Moertel, C. L. (CoI)
3/1/21 → 3/31/25
Project: Research project
-
A core outcome domain set to assess cutaneous neurofibromas related to neurofibromatosis type 1 in clinical trials
Fertitta, L., Bergqvist, C., Sarin, K. Y., Plotkin, S. R., Moertel, C., Petersen, A. K., Cannon, A., Berman, Y., Pichard, D. C., Röhl, C., Lessing, A., Brizion, B., Peiffer, B., Ravaud, P., Tran, V. T., Armand, M. L., Moryousef, S., Ferkal, S., Jannic, A. & Ezzedine, K. & 1 others, , Feb 2024, In: British Journal of Dermatology. 190, 2, p. 216-225 10 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children with Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma
ReNeu Trial Investigators, 2024, (Accepted/In press) In: Journal of Clinical Oncology. JCO.24.01034.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
The 8th International RASopathies Symposium: Expanding research and care practice through global collaboration and advocacy
Pierpont, E. I., Bennett, A. M., Schoyer, L., Stronach, B., Anschutz, A., Borrie, S. C., Briggs, B., Burkitt-Wright, E., Castel, P., Cirstea, I. C., Draaisma, F., Ellis, M., Fear, V. S., Frone, M. N., Flex, E., Gelb, B. D., Green, T., Gripp, K. W., Khoshkhoo, S. & Kieran, M. W. & 24 others, , Apr 2024, In: American Journal of Medical Genetics, Part A. 194, 4, e63477.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
The OTX2 Gene Induces Tumor Growth and Triggers Leptomeningeal Metastasis by Regulating the mTORC2 Signaling Pathway in Group 3 Medulloblastomas
Ampudia-Mesias, E., Cameron, C. S., Yoo, E., Kelly, M. D., Anderson, S. M., Manning, R., Abrahante Lloréns, J. E., Moertel, C. L., Yim, H., Odde, D. J., Saydam, N. & Saydam, O., Apr 2024, In: International journal of molecular sciences. 25, 8, 4416.Research output: Contribution to journal › Article › peer-review
Open Access -
Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1
Osum, S. H., Oribamise, E. I., Corbière, S. M. A. S., Taisto, M., Jubenville, T., Coutts, A., Kirstein, M. N., Fisher, J., Moertel, C., Du, M., Bedwell, D., Largaespada, D. A. & Watson, A. L., Sep 12 2023, In: Molecular Therapy Nucleic Acids. 33, p. 227-239 13 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations